VRSN Form 4: D. James Bidzos reports 2,000-share sale under 10b5-1 plan

Rhea-AI Filing Summary

D. James Bidzos, Verisign Inc. (VRSN) executive chairman, president and CEO, reported insider sales on 09/18/2025. He sold a total of 2,000 shares across four transactions at weighted-average prices in the ranges $285.94–$286.35, $287.05–$287.77 and $288.08–$288.95, and one trade at $289.32. Following these disposals his reported beneficial ownership stood at 476,438.7009 shares. The Form 4 indicates the transactions were covered by a written plan intended to satisfy Rule 10b5-1 affirmative defense.

Positive

• Transactions executed under a 10b5-1 written plan, which provides an affirmative defense and clarity on trading intent
• Reporting person retains substantial beneficial ownership at 476,438.7009 shares after the reported sales

Negative

• Executive-level insider sold 2,000 shares, which may be interpreted negatively by some investors despite plan coverage

Insights

Corporate Governance Expert

TL;DR: CEO sold 2,000 Verisign shares under a 10b5-1 plan; holding remains substantial at ~476,439 shares.

The filing shows routine insider sales executed on 09/18/2025 and documented under a Rule 10b5-1 plan, which is commonly used to avoid allegations of trading on material nonpublic information. The remaining beneficial ownership of 476,438.7009 shares indicates continued significant alignment with shareholders despite the small sale size relative to total holdings. No derivative transactions or additional disclosures were reported.

Securities Analyst

TL;DR: Modest outright disposals by the CEO; transactions are documented with weighted-average pricing and did not eliminate significant ownership.

Form 4 lists four dispositions totaling 2,000 shares with weighted-average prices disclosed and explanatory footnotes for price ranges. The stepwise decrease in post-transaction beneficial ownership is shown in the form. The presence of the 10b5-1 checkbox reduces ambiguity about timing intent. There are no reported option exercises, grants or other derivative activity in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BIDZOS D JAMES

(Last) (First) (Middle)

12061 BLUEMONT WAY

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERISIGN INC/CA [ VRSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Chairman, Pres, & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2025		S		266	D	$286.1242(1)	478,172.7009	D
Common Stock	09/18/2025		S		534	D	$287.3382(2)	477,638.7009	D
Common Stock	09/18/2025		S		1,100	D	$288.5864(3)	476,538.7009	D
Common Stock	09/18/2025		S		100	D	$289.32	476,438.7009	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $285.94 to $286.35, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $287.05 to $287.77, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $288.08 to $288.95, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

	Thomas C. Indelicarto by Power of Attorney for D. James Bidzos	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Verisign (VRSN) shares did D. James Bidzos sell on 09/18/2025?

He sold a total of 2,000 shares across four transactions on 09/18/2025.

At what prices were the VRSN shares sold according to the Form 4?

The filing reports weighted-average prices with ranges: $285.94–$286.35, $287.05–$287.77, $288.08–$288.95, and one trade at $289.32.

Was the sale by D. James Bidzos part of a Rule 10b5-1 plan?

Yes. The Form 4 indicates the transaction was made pursuant to a written plan intended to satisfy Rule 10b5-1(c) affirmative defense.

What is Bidzos’s beneficial ownership of VRSN after these transactions?

The Form 4 reports beneficial ownership of 476,438.7009 shares following the reported transactions.

Does the Form 4 report any derivative transactions or option activity?

No. Table II for derivative securities shows no derivative transactions reported in this filing.